Dystonias and other involuntary movements
Drug Safety update
December 2014: Botulinum toxin products: rare but serious risks
NICE Guidance (see also drug-specific link below)
Xeomin (botulinum neurotoxin type A) is recommended as an option for treating chronic sialorrhoea caused by neurological conditions in adults according to NICE TA 605.
Caution: Due to unit differences in the potency assay, unit doses for different brands of Botulinum A toxin are NOT interchangeable.
| Pack |
|---|
| 1 vial |
| Pack |
|---|
| 1 vial |
| Pack |
|---|
| 1 vial |
| Pack |
|---|
| 1 vial |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary